TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Charles F Craddock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.